InvestorsHub Logo
Followers 18
Posts 1439
Boards Moderated 0
Alias Born 11/01/2018

Re: None

Saturday, 02/10/2024 4:09:16 PM

Saturday, February 10, 2024 4:09:16 PM

Post# of 459726
Cassava Sciences And Alzheimer's Disease: Opaque Clarity---Lane Simonian

"The true impact of simufilam on mild Alzheimer's disease patients is unknown, making it difficult to assess the drug's effectiveness for this group".

So why doesn't SAVA stock price get hammered down by 40% ? - Manipulation

https://seekingalpha.com/article/4669252-cassava-sciences-alzheimers-disease-opaque-clarity?mailingid=34308843&messageid=must_reads&serial=34308843.1384467&utm_campaign=email_mr%3Aevergreen_lp_premium_test_eligible_feb2024%2B2024-02-10&utm_content=seeking_alpha&utm_medium=email&utm_source=seeking_alpha&utm_term=must_reads_free_eligible
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News